These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 5609866)

  • 1. [Collateral toxic effects of antitubercular drugs: acute psychopathies caused by cycloserine. (Case reports)].
    Zanotelli F; Ghidini O; Bertoni L
    G Clin Med; 1967 Sep; 48(9):972-84. PubMed ID: 5609866
    [No Abstract]   [Full Text] [Related]  

  • 2. [Side effects of antibacterial drugs in the clinical course of pulmonary tuberculosis].
    Czkwianianc M; Markiewicz I
    Przegl Lek; 1969 Jun; 25(6):479-81. PubMed ID: 5805095
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rheumatic diseases caused by antitubercular drugs].
    Anastasatu C; Stoia I; Kaufman S; Ghenoiu O; Iancovici O
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Jan; 136(1):51-63. PubMed ID: 4538033
    [No Abstract]   [Full Text] [Related]  

  • 4. Pyridoxine-responsive sideroblastic anemia due to antituberculous drugs.
    Haden HT
    Arch Intern Med; 1967 Nov; 120(5):602-6. PubMed ID: 6054596
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of multi-drug resistant tuberculosis showing psychiatric adverse effect by cycloserine].
    Fujita J; Sunada K; Hayashi H; Hayashihara K; Saito T
    Kekkaku; 2008 Jan; 83(1):21-5. PubMed ID: 18283911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the electroencephalogram and neuro-psychic disorders in patients with pulmonary tuberculosis during treatment with cycloserine].
    Chelnokova NV
    Antibiotiki; 1968 Oct; 13(10):918-25. PubMed ID: 5707364
    [No Abstract]   [Full Text] [Related]  

  • 7. [Manifestations of a rheumatic type caused by antituberculosis chemotherapy].
    Anastasatu C; Kauffmann S; Iancovici O
    Med Interna (Bucur); 1969 May; 21(5):557-60. PubMed ID: 5307329
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on the adverse effects of secondary antituberculous drugs, with special reference to mental disorders induced by cycloserine and ethionamide].
    Ono K; Hashigami Y; Itonaga K; Aida Y; Fujino S
    Iryo; 1969 Jan; 23(1):85-91. PubMed ID: 5783221
    [No Abstract]   [Full Text] [Related]  

  • 9. [The therapy of pulmonary tuberculosis in psychopathic patients, using terizidone].
    Micheletti V; Teti V; Fenzi P; Usberti G
    Minerva Med; 1968 May; 59(42):2459-65. PubMed ID: 5653337
    [No Abstract]   [Full Text] [Related]  

  • 10. [Terisidon in chemotherapy of pulmonary tuberculosis].
    Kolosovskaia VP; Korotaev GA
    Probl Tuberk; 1974; (12):15-8. PubMed ID: 4445129
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of clinical trials of a new antitubercular agent, terizidone (Terivalidine)].
    Zrilić V; Mijatović M; Mirković S; Muzikravić T
    Plucne Bolesti Tuberk; 1972; 24(2):89-98. PubMed ID: 4565191
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparison of the effects of the combined therapy with CPM+1321 TH+CS, KM+1321 TH+CS and KM+1314 TH+CS in the treatment of pulmonary tuberculosis].
    Iizuka Y; Iwasaki T; Fujioka K
    Kekkaku; 1969 Mar; 44(3):109-15. PubMed ID: 5783307
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 14. [Triple placebo test for comparison of side effects of terizidone (terivalidin) and cycloserine].
    Böszörményi M
    Int J Clin Pharmacol; 1973 Aug; 8(1):37-41. PubMed ID: 4580381
    [No Abstract]   [Full Text] [Related]  

  • 15. Suicide of two patients during the postoperative course after pulmonary resection: possible effect of cycloserine.
    Esteves Pinto E
    Scand J Respir Dis Suppl; 1970; 71():256-8. PubMed ID: 5271997
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the patients' mental status in the tolerability of antituberculous drugs].
    Mordyk AV; Briukhanova NS; Kazakov AV
    Probl Tuberk Bolezn Legk; 2009; (3):38-42. PubMed ID: 19455986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anaphylactic shock caused by antitubercular drugs in a case of tuberculosis with primary resistance to 4 drugs].
    Rózewska M; Graczyk J
    Gruzlica; 1970 Mar; 38(3):257-60. PubMed ID: 5527050
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of tuberculosis in persons with mental diseases].
    Shcherbatiuk AS; Sabanov AI
    Probl Tuberk; 1980 Jan; (1):48-51. PubMed ID: 7367424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.